Related Experiment Video
Updated: May 26, 2026

Preparation Of Neovascular Tissues from Human Glioma Tissues for Quantitative Proteomics Analysis of Tumor Angiogenesis
Published on: March 20, 2026
Autophagy in brain tumors: a new target for therapeutic intervention
Niroop Kaza1, Latika Kohli, Kevin A Roth
1Department of Pathology, University of Alabama at Birmingham, Birmingham, AL 35294-0017, USA.
Abstract:
The role of autophagy, traditionally considered a cellular homeostatic and recycling mechanism, has expanded dramatically to include an involvement in discrete stages of tumor initiation and development. Gliomas are the most aggressive and also the most common brain malignancies. Current treatment modalities have only a modest effect on patient outcomes. Resistance to apoptosis, a hallmark of most cancers, has driven the search for novel targets in cancer therapy. The autophagy lysosomal pathway is one such target that is being explored in multiple cancers including gliomas and is a promising avenue for further therapeutic development. This review summarizes our current understanding of the autophagic process and its potential utility as a target for glioma therapy.
Insights
Autophagy, a cellular process, plays a key role in glioma development and presents a promising therapeutic target. Understanding this pathway could lead to new treatments for aggressive brain tumors.
Area of Science:
- Oncology
- Cell Biology
- Neuroscience
Background:
- Autophagy is a cellular recycling process with a newly recognized role in cancer development.
- Gliomas are aggressive brain tumors with limited treatment options.
- Apoptosis resistance is a common feature in cancers, driving the search for new therapeutic targets.
Purpose of the Study:
- To review the current understanding of autophagy.
- To explore the role of autophagy in glioma initiation and progression.
- To evaluate autophagy as a potential therapeutic target for glioma treatment.
Main Methods:
- Literature review of studies on autophagy and gliomas.
- Analysis of the autophagic lysosomal pathway in cancer.
- Synthesis of current research on therapeutic strategies targeting autophagy.
Main Results:
- Autophagy is implicated in multiple stages of tumor development, including gliomas.
- The autophagy lysosomal pathway is a viable target for novel cancer therapies.
- Targeting autophagy may offer a new strategy to overcome treatment resistance in gliomas.
Conclusions:
- Autophagy is a critical process in glioma pathogenesis.
- The autophagy lysosomal pathway represents a promising therapeutic target for gliomas.
- Further research into modulating autophagy could significantly improve glioma patient outcomes.
Related Concept Videos
Autophagy
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Drugs that Stabilize Microtubules
Delivery Pathways to the Lysosome
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...

